Literature DB >> 18721724

Complications of foldable intraocular lenses requiring explantation or secondary intervention--2007 survey update.

Nick Mamalis1, Jacob Brubaker, Don Davis, Ladan Espandar, Liliana Werner.   

Abstract

The tenth annual survey of complications associated with foldable intraocular lenses (IOLs) requiring explantation or secondary intervention was sent to members of the American Society of Cataract and Refractive Surgery and the European Society of Cataract and Refractive Surgeons. Preoperative data about visual acuity, patient signs and symptoms, and complications requiring IOL removal were evaluated. Complications were then tabulated for each of the following major foldable IOL groups: 1-piece (plate) silicone, 1-piece hydrophobic acrylic with haptics, 3-piece silicone, 3-piece hydrophobic acrylic, 3-piece hydrophilic acrylic (hydrogel), 3-piece unknown, multifocal acrylic, and multifocal silicone. One hundred forty-two surveys were returned for evaluation. Dislocation/decentration, incorrect IOL power, glare/optical aberrations, and IOL calcification were the most common reasons for removing foldable IOLs. Good surgical technique, accurate IOL power measurements, and high manufacturing standards for foldable IOL materials and designs are the most important factors in preventing complications.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18721724     DOI: 10.1016/j.jcrs.2008.05.046

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  26 in total

1.  Corrective Techniques and Future Directions for Treatment of Residual Refractive Error Following Cataract Surgery.

Authors:  Majid Moshirfar; Michael V McCaughey; Luis Santiago-Caban
Journal:  Expert Rev Ophthalmol       Date:  2014-12

Review 2.  Do we need day-1 postoperative follow-up after cataract surgery?

Authors:  Andrzej Grzybowski; Piotr Kanclerz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-12-19       Impact factor: 3.117

3.  Assessment of a new hydrophilic acrylic supplementary IOL for sulcus fixation in pseudophakic cadaver eyes.

Authors:  N Reiter; L Werner; J Guan; J Li; K T Tsaousis; N Mamalis; S Srinivasan
Journal:  Eye (Lond)       Date:  2017-01-20       Impact factor: 3.775

4.  Validation of a spectral light scattering method to differentiate large from small particles in intraocular lenses.

Authors:  Grzegorz Łabuz; Eleni Papadatou; Fernando Vargas-Martín; Norberto López-Gil; Nicolaas J Reus; Thomas J T P van den Berg
Journal:  Biomed Opt Express       Date:  2017-02-27       Impact factor: 3.732

5.  Postoperative diffuse opacification of a hydrophilic acrylic intraocular lens: analysis of an explant.

Authors:  Gian Maria Cavallini; Veronica Volante; Luca Campi; Michele De Maria; Elisa Fornasari; Giancarlo Urso
Journal:  Int Ophthalmol       Date:  2017-06-14       Impact factor: 2.031

6.  A pilot study of intraocular lens explantation in 69 eyes in Chinese patients.

Authors:  Fang Chai; Bo Ma; Xin-Guang Yang; Juan Li; Mei-Fang Chu
Journal:  Int J Ophthalmol       Date:  2017-04-18       Impact factor: 1.779

7.  Intraocular lens explantation in Chinese patients: different patterns and different responses.

Authors:  Tommy C Y Chan; Jerry K H Lok; Vishal Jhanji; Victoria W Y Wong
Journal:  Int Ophthalmol       Date:  2014-09-03       Impact factor: 2.031

8.  Intraocular lens explantation in Spain: indications and outcomes at a tertiary referral center from 2010 to 2018.

Authors:  Mª Victoria de Rojas; Sara Viña; Antía Gestoso; Patricia Simón; Marcelino Álvarez
Journal:  Int Ophthalmol       Date:  2019-09-29       Impact factor: 2.031

9.  Intraocular lens exchange-removing the optic intact.

Authors:  Matthew Hao Lee; Diane Lesley Webster
Journal:  Int J Ophthalmol       Date:  2016-06-18       Impact factor: 1.779

10.  Risk of late intraocular lens dislocation after cataract surgery, 1980-2009: a population-based study.

Authors:  Sam L Pueringer; David O Hodge; Jay C Erie
Journal:  Am J Ophthalmol       Date:  2011-06-17       Impact factor: 5.258

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.